SG Americas Securities, LLC - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 211 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q4 2022. The put-call ratio across all filers is 0.20 and the average weighting 0.1%.

Quarter-by-quarter ownership
SG Americas Securities, LLC ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$2,333
+268.6%
50,727
+200.7%
0.03%
+285.7%
Q1 2023$633
+113.1%
16,870
+59.3%
0.01%
+75.0%
Q4 2022$297
-99.8%
10,588
+138.8%
0.00%
+100.0%
Q3 2022$125,000
-68.4%
4,434
-61.0%
0.00%
-50.0%
Q2 2022$396,000
-3.2%
11,382
-0.2%
0.00%
+33.3%
Q1 2022$409,000
-51.1%
11,401
-68.3%
0.00%
-40.0%
Q4 2021$837,000
-44.7%
35,947
-54.8%
0.01%
-28.6%
Q3 2021$1,513,000
+1398.0%
79,603
+1350.8%
0.01%
+600.0%
Q1 2021$101,000
-93.6%
5,487
-93.5%
0.00%
-90.0%
Q3 2020$1,572,000
+678.2%
83,818
+514.5%
0.01%
+400.0%
Q1 2020$202,000
+48.5%
13,640
+94.1%
0.00%
+100.0%
Q4 2019$136,000
-64.9%
7,028
-62.9%
0.00%
-75.0%
Q1 2019$387,000
+140.4%
18,933
+133.4%
0.00%
+300.0%
Q4 2018$161,0000.0%8,112
-23.1%
0.00%0.0%
Q2 2018$161,000
-45.1%
10,544
-35.6%
0.00%
-66.7%
Q3 2017$293,000
+164.0%
16,385
+164.7%
0.00%
+200.0%
Q2 2017$111,000
-73.9%
6,190
-73.2%
0.00%
-75.0%
Q4 2016$426,00023,1020.00%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q4 2022
NameSharesValueWeighting ↓
LAM GROUP, INC. 130,250$3,649,6053.75%
SHAKER INVESTMENTS LLC/OH 81,287$2,277,6621.41%
Mesirow Institutional Investment Management, Inc. 374,414$10,491,0801.38%
OBERWEIS ASSET MANAGEMENT INC/ 134,000$3,754,6800.80%
Portolan Capital Management 270,791$7,587,5640.75%
Hillsdale Investment Management Inc. 172,238$4,826,1090.41%
Capital Impact Advisors, LLC 14,669$411,0250.40%
Watershed Asset Management, L.L.C. 9,555$267,7310.34%
Quantedge Capital Pte Ltd 35,153$984,9870.33%
FEDERATED HERMES, INC. 3,284,217$92,023,7600.25%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders